14 results
8-K
EX-99.1
STIM
Neuronetics Inc
8 Nov 22
Neuronetics Reports Third Quarter 2022 Financial and Operating Results
7:32am
impacts of our ongoing strategic initiatives such as the revamped sales force, innovative marketing programs, and continued physician and patient
8-K
EX-99.1
STIM
Neuronetics Inc
8 Mar 22
Neuronetics Reports Fourth Quarter and Full Year 2021 Financial and Operating Results
7:32am
Recent Operational Highlights
Attained 510(k) clearance of innovative MT Cap technology for NeuroStar, designed to make the motor threshold
8-K
EX-99.1
yaz593xpyvthnr29
6 Mar 20
Neuronetics, Inc. announces Chris Thatcher will step down as President and CEO
5:06pm
8-K
EX-99.1
iyponoojk20gn8yqf
2 Jul 19
Neuronetics Appoints Stephen Furlong as Chief Financial Officer
5:17pm
10-K
afj2em zpx4ml7afi
5 Mar 19
Annual report
12:00am
8-K
EX-99.1
u5m9cwdonmgvk2
15 Feb 19
Neuronetics, Inc. Announces Appointment of Dr. Cheryl R. Blanchard to its Board of Directors
8:05am
424B4
tqz7i bsfea9z4
29 Jun 18
Prospectus supplement with pricing info
4:02pm
S-1/A
arjgmgg
15 Jun 18
IPO registration (amended)
12:00am
S-1
nn68fwu3ufux89mbc
31 May 18
IPO registration
12:33pm
DRS/A
0s2d29agbn9zi
29 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next